Johannes Gutenberg University of Mainz's cancer therapy developer raised $150m despite reducing the number of shares in the IPO and floating beneath its range.
The underwriters for Karolinska Institute spinout Aprea Therapeutics have taken up the over-allotment option in full to boost proceeds to nearly $97.8m.
Founded from University of Surrey's Space Centre, iKinema was bought by Apple in a move seemingly aligned with the corporate's foray into virtual and augmented reality.
Karolinska Institute's Aprea Therapeutics has priced its shares at $15 to raise $85m, with stock rising a third to $20.50 on the first day of trading.
Frequency, a regenerative medicine developer based on MIT and Harvard research, priced shares at the bottom of its range to raise $84m in its IPO.
Infineon Technologies Austria has bought its portfolio company Dice, a Johannes Kepler University spinout that produces integrated circuits for radar-powered sensors.